Sponsor Dossier
Bayer
Sponsor Dossier for Bayer. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADEMPAS
- Brand: AERIUS
- Brand: ALEVE
- Brand: ALKA-SELTZER
- Brand: Allergy
- Brand: Am-o-lin
- Brand: ANGELIQ
- Brand: ASPRO
- Device (sponsor): Nasal irrigation saline solution, non-sterile
- Device (sponsor): Electric infusion pump administration set
- Device (sponsor): Needle, scalp vein
- Device (sponsor): Adhesive strip, skin-cover
- Device (sponsor): Scraper, cytology, reusable
- Device (sponsor): Clinical chemistry biological screening IVDs
- Device (sponsor): Injector, medication/vaccine, syringe
- Device (sponsor): Nail treatment solution
- Device (sponsor): Adhesive strip, <specify>
- Device (sponsor): Non-sterile scar management dressing, single-use
- Device (sponsor): Wound dressing kit
- Device (sponsor): Scraper, cytology, reusable
- Device (sponsor): Patch, nail
- Device (sponsor): Adhesive tape, general-purpose, waterproof
- Device (sponsor): Vial adaptor, hermetic
- Device (sponsor): Wet wipe
- Device (sponsor): Wet wipe
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Wet wipe
- Device (sponsor): Adaptor, syringe/needle
- Device (sponsor): Intravenous administration set, scalp vein
- Device (sponsor): Needle, hypodermic
- Device (sponsor): Ampule opener
- Device (sponsor): Medicine administration kit, percutaneous, non-medicated, single-use
- Device (sponsor): Adaptor, luer
- Device (sponsor): Vaginal applicators - Medicine administration kit, <specify>
About
Bayer is an Australian Public Company with ABN 22000138714, based in NSW and currently active.
Portfolio
Bayer has 78 brands on the ARTG, of which 45 are indexable. The portfolio includes 42 brands with Product Information on file, 17 brands with at least one PBS-listed item, 15 brands with PBAC outcomes on record, and 11 brands with AusPARs on record.
Therapeutic focus
— Reproductive Health: 16 brands — Women's Health: 9 brands — Complementary Medicine: 7 brands — Respiratory: 6 brands — Oncology: 5 brands — Cardiology: 5 brands — Neurology: 4 brands — Dermatology: 3 brands — Ophthalmology: 3 brands — Gastroenterology: 3 brands — Pain & Anaesthesia: 3 brands — Other: 3 brands — Infectious Disease: 2 brands — Haematology: 2 brands — Immunology: 2 brands — Urology: 2 brands — Hepatology: 1 brand — Pain Management: 1 brand — Endocrinology: 1 brand
PBS footprint
Seventeen brands in the portfolio have at least one PBS-listed item, with the latest PBS schedule date touched on 2026-05-01.
Regulatory activity
The portfolio has 15 brands with PBAC outcomes on record, with the most recent outcome dated 2024-11-01. Eleven brands have AusPARs on record, with the latest AusPAR dated 2023-03-21.